BDTX Black Diamond Therapeutics, Inc.
Healthcare$2.33+2.19%ClosedMarket Cap: $133.5M
As of 2026-05-26
Valuation
P/E (TTM)
6.56
PEG
0.05
P/B
1.25
P/S
0.00
EV/EBITDA
-2.94
DCF Value
$10.89
FCF Yield
-26.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-36.4%
ROA
-32.5%
ROIC
-43.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-11.3M | $-9.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-17.6M | $-15.1M | $— | — |
| FY null | $70.0M | 99.5% | $19.9M | $22.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-11.0M | $-8.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-13.4M | $-10.6M | $— | — |
| Q1 null | $70.0M | 100.0% | $54.5M | $56.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-18.3M | $-16.0M | $— | — |
| FY null | $0.00 | NaN% | $-78.8M | $-69.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-18.1M | $-15.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-22.1M | $-19.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-20.2M | $-18.2M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-20.9M | $-19.4M | $-0.41 | — |